- £3.60bn
- £4.86bn
- $3.35bn
Hikma Pharmaceutical - Director/PDMR Shareholding
Press Digest: British Business - March 30
Hikma Pharmaceutical - Annual Financial Report and Notice of AGM
Europe Research Roundup: Epiroc , Neste , Wacker Chemie
Hikma Pharmaceutical - Director/PDMR Shareholding
IG Group, Lion Finance to enter FTSE 100; Easyjet, Hikma dropped
Europe Research Roundup: Danone, Emeis, Sandoz Group
Europe Research Roundup: Aixtron, Ferrari, Orsted
Live Markets: Markets still underpricing public-private nuclear push - WisdomTree
Live Markets: To survive a fractured world, ditch the old rulebook
Live Markets: Utilities and industrials keep STOXX high
UK's Hikma shares plunge on weak sales forecast
UK's Hikma warns of slower sales growth, withdraws medium-term outlook (updated)
UK Stocks-Factors to watch on February 26 (updated)
Brief: Hikma Says Buyback Programme Valued At US $250 Million
UK's Hikma posts higher annual revenue on strong injectables segment
Hikma Pharmaceutical - Final Results, Share Buyback & Leadership Changes
UK Stocks-Factors to watch on February 26
Deals of the day-Mergers and acquisitions